These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 12397073)
1. Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease. Alves Da Costa C; Paitel E; Vincent B; Checler F J Biol Chem; 2002 Dec; 277(52):50980-4. PubMed ID: 12397073 [TBL] [Abstract][Full Text] [Related]
2. Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease. da Costa CA; Masliah E; Checler F J Biol Chem; 2003 Sep; 278(39):37330-5. PubMed ID: 12867415 [TBL] [Abstract][Full Text] [Related]
3. 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation. Alves da Costa C; Dunys J; Brau F; Wilk S; Cappai R; Checler F J Biol Chem; 2006 Apr; 281(14):9824-31. PubMed ID: 16464850 [TBL] [Abstract][Full Text] [Related]
4. Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli. da Costa CA; Ancolio K; Checler F J Biol Chem; 2000 Aug; 275(31):24065-9. PubMed ID: 10818098 [TBL] [Abstract][Full Text] [Related]
5. Caspase-3-derived C-terminal product of synphilin-1 displays antiapoptotic function via modulation of the p53-dependent cell death pathway. Giaime E; Sunyach C; Herrant M; Grosso S; Auberger P; McLean PJ; Checler F; da Costa CA J Biol Chem; 2006 Apr; 281(17):11515-22. PubMed ID: 16495229 [TBL] [Abstract][Full Text] [Related]
6. Antiapoptotic property of human alpha-synuclein in neuronal cell lines is associated with the inhibition of caspase-3 but not caspase-9 activity. Li W; Lee MK J Neurochem; 2005 Jun; 93(6):1542-50. PubMed ID: 15935070 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Zhou W; Hurlbert MS; Schaack J; Prasad KN; Freed CR Brain Res; 2000 Jun; 866(1-2):33-43. PubMed ID: 10825478 [TBL] [Abstract][Full Text] [Related]
9. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198 [TBL] [Abstract][Full Text] [Related]
10. Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation. Paitel E; Fahraeus R; Checler F J Biol Chem; 2003 Mar; 278(12):10061-6. PubMed ID: 12529324 [TBL] [Abstract][Full Text] [Related]
11. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Xu J; Kao SY; Lee FJ; Song W; Jin LW; Yankner BA Nat Med; 2002 Jun; 8(6):600-6. PubMed ID: 12042811 [TBL] [Abstract][Full Text] [Related]
12. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Tanaka Y; Engelender S; Igarashi S; Rao RK; Wanner T; Tanzi RE; Sawa A; L Dawson V; Dawson TM; Ross CA Hum Mol Genet; 2001 Apr; 10(9):919-26. PubMed ID: 11309365 [TBL] [Abstract][Full Text] [Related]
13. Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons. Stefanis L; Wang Q; Oo T; Lang-Rollin I; Burke RE; Dauer WT Eur J Neurosci; 2004 Oct; 20(7):1969-72. PubMed ID: 15380020 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
15. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. Tanaka M; Kim YM; Lee G; Junn E; Iwatsubo T; Mouradian MM J Biol Chem; 2004 Feb; 279(6):4625-31. PubMed ID: 14627698 [TBL] [Abstract][Full Text] [Related]
16. Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels. Paitel E; Sunyach C; Alves da Costa C; Bourdon JC; Vincent B; Checler F J Biol Chem; 2004 Jan; 279(1):612-8. PubMed ID: 14570892 [TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease. Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146 [TBL] [Abstract][Full Text] [Related]
18. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403 [TBL] [Abstract][Full Text] [Related]
19. HSP27 but not HSP70 has a potent protective effect against alpha-synuclein-induced cell death in mammalian neuronal cells. Zourlidou A; Payne Smith MD; Latchman DS J Neurochem; 2004 Mar; 88(6):1439-48. PubMed ID: 15009645 [TBL] [Abstract][Full Text] [Related]
20. p53-Dependent Aph-1 and Pen-2 anti-apoptotic phenotype requires the integrity of the gamma-secretase complex but is independent of its activity. Dunys J; Kawarai T; Sevalle J; Dolcini V; George-Hyslop PS; Da Costa CA; Checler F J Biol Chem; 2007 Apr; 282(14):10516-25. PubMed ID: 17276981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]